Read as much as you want on BostonGlobe.com, anywhere and anytime, for just 99¢.

Edwards Lifesciences stock falls as sales disappoint

Continue reading below

Edwards Lifesciences Corp. lost more than a fifth of its market value as it turned in the biggest decline on the S&P 500. The company, which makes a less-invasive heart valve, generated an estimated $448 million in sales during the latest quarter, less than the $465 million to $485 million that was estimated in July, the company said.

Loading comments...

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week